Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein Kinase Inhibitors | 15 | 2024 | 5643 | 0.590 |
Why?
|
Cyclin-Dependent Kinases | 3 | 2022 | 656 | 0.440 |
Why?
|
Proto-Oncogene Proteins c-met | 3 | 2024 | 567 | 0.440 |
Why?
|
Cysteine | 3 | 2023 | 895 | 0.310 |
Why?
|
Protein Kinases | 3 | 2024 | 1612 | 0.300 |
Why?
|
Pyrimidines | 8 | 2024 | 3016 | 0.260 |
Why?
|
Drug Discovery | 5 | 2021 | 1057 | 0.260 |
Why?
|
src-Family Kinases | 3 | 2020 | 535 | 0.220 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2024 | 211 | 0.220 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2022 | 1889 | 0.220 |
Why?
|
Mitogen-Activated Protein Kinase 9 | 1 | 2023 | 31 | 0.220 |
Why?
|
Drug Design | 5 | 2021 | 1061 | 0.210 |
Why?
|
MAP Kinase Kinase 4 | 2 | 2020 | 149 | 0.200 |
Why?
|
Chromatography, Affinity | 1 | 2023 | 534 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-hck | 1 | 2021 | 46 | 0.200 |
Why?
|
Molecular Probes | 1 | 2023 | 313 | 0.190 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2023 | 444 | 0.190 |
Why?
|
MAP Kinase Kinase 7 | 1 | 2020 | 14 | 0.180 |
Why?
|
Creatine Kinase | 1 | 2023 | 691 | 0.180 |
Why?
|
Creatine | 1 | 2023 | 426 | 0.180 |
Why?
|
Peptide Termination Factors | 1 | 2020 | 56 | 0.180 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2021 | 256 | 0.170 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2022 | 376 | 0.170 |
Why?
|
CDC2 Protein Kinase | 1 | 2020 | 213 | 0.170 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 3 | 2023 | 186 | 0.170 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 2 | 2009 | 93 | 0.160 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2022 | 563 | 0.160 |
Why?
|
TRPM Cation Channels | 1 | 2020 | 139 | 0.160 |
Why?
|
Point Mutation | 1 | 2024 | 1594 | 0.160 |
Why?
|
Geologic Sediments | 1 | 2019 | 79 | 0.160 |
Why?
|
Bacillus | 1 | 2019 | 78 | 0.160 |
Why?
|
Seawater | 1 | 2019 | 120 | 0.160 |
Why?
|
Cholangiocarcinoma | 1 | 2024 | 550 | 0.150 |
Why?
|
Bile Duct Neoplasms | 1 | 2024 | 602 | 0.150 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1135 | 0.150 |
Why?
|
Lactic Acid | 1 | 2023 | 1134 | 0.150 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2021 | 581 | 0.140 |
Why?
|
Carcinoma, Renal Cell | 3 | 2020 | 3218 | 0.140 |
Why?
|
Anilides | 1 | 2020 | 409 | 0.140 |
Why?
|
Lymphoma, B-Cell | 1 | 2023 | 935 | 0.140 |
Why?
|
Small Molecule Libraries | 2 | 2020 | 734 | 0.140 |
Why?
|
Adenine | 1 | 2021 | 975 | 0.130 |
Why?
|
Cell Line, Tumor | 10 | 2024 | 16939 | 0.130 |
Why?
|
Kidney Neoplasms | 3 | 2020 | 4312 | 0.130 |
Why?
|
Neoplasms | 5 | 2023 | 22072 | 0.120 |
Why?
|
Thalidomide | 1 | 2020 | 884 | 0.120 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 730 | 0.120 |
Why?
|
Cell Cycle | 1 | 2023 | 2934 | 0.120 |
Why?
|
Exons | 1 | 2020 | 2388 | 0.110 |
Why?
|
Benzimidazoles | 2 | 2009 | 858 | 0.110 |
Why?
|
Cell Proliferation | 8 | 2023 | 10446 | 0.110 |
Why?
|
Cell Cycle Proteins | 2 | 2023 | 3446 | 0.110 |
Why?
|
Phylogeny | 2 | 2019 | 2775 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2864 | 0.110 |
Why?
|
Piperidines | 1 | 2021 | 1650 | 0.110 |
Why?
|
Structure-Activity Relationship | 5 | 2022 | 3084 | 0.110 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2023 | 5253 | 0.100 |
Why?
|
Lymphoma | 1 | 2021 | 1898 | 0.100 |
Why?
|
Fusion Proteins, bcr-abl | 2 | 2010 | 431 | 0.090 |
Why?
|
Anthracenes | 1 | 2011 | 83 | 0.090 |
Why?
|
Peptides | 1 | 2023 | 4354 | 0.090 |
Why?
|
Apoptosis | 3 | 2023 | 9501 | 0.090 |
Why?
|
Proteome | 1 | 2020 | 1855 | 0.090 |
Why?
|
Antineoplastic Agents | 5 | 2023 | 13630 | 0.090 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13262 | 0.090 |
Why?
|
Dietary Fiber | 1 | 2014 | 760 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2895 | 0.090 |
Why?
|
Neutrophils | 1 | 2022 | 3767 | 0.080 |
Why?
|
Plasmodium | 1 | 2011 | 247 | 0.080 |
Why?
|
Biocatalysis | 1 | 2009 | 172 | 0.080 |
Why?
|
Molecular Structure | 4 | 2020 | 1895 | 0.080 |
Why?
|
Static Electricity | 1 | 2009 | 261 | 0.080 |
Why?
|
Enzyme Inhibitors | 2 | 2011 | 3726 | 0.080 |
Why?
|
Pyrazines | 1 | 2013 | 1199 | 0.070 |
Why?
|
Phosphorylation | 4 | 2023 | 8313 | 0.070 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2008 | 276 | 0.070 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2014 | 800 | 0.070 |
Why?
|
Transcription Factors | 4 | 2023 | 12103 | 0.070 |
Why?
|
Adenosine Triphosphate | 2 | 2024 | 1993 | 0.070 |
Why?
|
Animals | 16 | 2024 | 167963 | 0.070 |
Why?
|
Mutation | 6 | 2024 | 29932 | 0.070 |
Why?
|
Mice | 11 | 2024 | 81208 | 0.070 |
Why?
|
Models, Molecular | 4 | 2020 | 5434 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2023 | 9585 | 0.060 |
Why?
|
Imidazoles | 1 | 2011 | 1180 | 0.060 |
Why?
|
Conserved Sequence | 1 | 2009 | 1167 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 6029 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2023 | 5791 | 0.060 |
Why?
|
Antimalarials | 1 | 2011 | 906 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 2011 | 1023 | 0.060 |
Why?
|
Proteomics | 3 | 2023 | 3817 | 0.060 |
Why?
|
Piperazines | 2 | 2011 | 2525 | 0.060 |
Why?
|
Signal Transduction | 6 | 2024 | 23376 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2023 | 74 | 0.050 |
Why?
|
Anaphase | 1 | 2023 | 116 | 0.050 |
Why?
|
SOXC Transcription Factors | 1 | 2022 | 41 | 0.050 |
Why?
|
Humans | 26 | 2024 | 760621 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2024 | 296 | 0.050 |
Why?
|
Ischemia | 1 | 2011 | 1893 | 0.050 |
Why?
|
Phosphotransferases | 1 | 2023 | 303 | 0.050 |
Why?
|
Lipoylation | 1 | 2022 | 88 | 0.050 |
Why?
|
Malaria | 1 | 2011 | 1226 | 0.050 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2022 | 183 | 0.050 |
Why?
|
Pyridines | 1 | 2013 | 2879 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2014 | 2276 | 0.050 |
Why?
|
Endoribonucleases | 1 | 2023 | 229 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5251 | 0.050 |
Why?
|
Poly A | 1 | 2021 | 181 | 0.050 |
Why?
|
Poly Adenosine Diphosphate Ribose | 1 | 2021 | 50 | 0.050 |
Why?
|
Drug Resistance | 2 | 2021 | 1617 | 0.050 |
Why?
|
Ubiquitins | 1 | 2022 | 370 | 0.050 |
Why?
|
Hydrogen Bonding | 1 | 2020 | 291 | 0.040 |
Why?
|
Diaminopimelic Acid | 1 | 2019 | 6 | 0.040 |
Why?
|
Vitamin K 2 | 1 | 2019 | 47 | 0.040 |
Why?
|
Base Composition | 1 | 2019 | 290 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2020 | 736 | 0.040 |
Why?
|
Databases, Protein | 1 | 2020 | 388 | 0.040 |
Why?
|
Bacterial Typing Techniques | 1 | 2019 | 260 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1697 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2020 | 8515 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2023 | 1246 | 0.040 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 529 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2020 | 929 | 0.040 |
Why?
|
Mitosis | 1 | 2023 | 1191 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 1 | 2019 | 1304 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1131 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2020 | 6216 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 717 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1837 | 0.040 |
Why?
|
Peptidoglycan | 1 | 2019 | 250 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2013 | 7850 | 0.030 |
Why?
|
Mice, SCID | 1 | 2021 | 2627 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2022 | 1755 | 0.030 |
Why?
|
Blotting, Western | 2 | 2014 | 5039 | 0.030 |
Why?
|
Cell Wall | 1 | 2019 | 425 | 0.030 |
Why?
|
Liver | 1 | 2011 | 7509 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1613 | 0.030 |
Why?
|
Kidney | 1 | 2011 | 7064 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3276 | 0.030 |
Why?
|
Cell Movement | 2 | 2020 | 5206 | 0.030 |
Why?
|
Phospholipids | 1 | 2019 | 789 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 1006 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2023 | 1596 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2020 | 1313 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2022 | 2379 | 0.030 |
Why?
|
Fabaceae | 1 | 2014 | 103 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1456 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2448 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6131 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6544 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2020 | 13451 | 0.030 |
Why?
|
Radioligand Assay | 1 | 2013 | 366 | 0.030 |
Why?
|
Mice, Nude | 1 | 2020 | 3607 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2022 | 2050 | 0.030 |
Why?
|
China | 1 | 2019 | 2339 | 0.030 |
Why?
|
Protein Conformation | 1 | 2020 | 3969 | 0.030 |
Why?
|
Cell Line | 2 | 2020 | 15620 | 0.020 |
Why?
|
Plasmodium yoelii | 1 | 2011 | 42 | 0.020 |
Why?
|
Acyltransferases | 1 | 2013 | 305 | 0.020 |
Why?
|
Sporozoites | 1 | 2011 | 82 | 0.020 |
Why?
|
Fatty Acids | 1 | 2019 | 1804 | 0.020 |
Why?
|
DNA Damage | 1 | 2021 | 2442 | 0.020 |
Why?
|
Plasmodium berghei | 1 | 2011 | 159 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2022 | 3610 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2011 | 825 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2014 | 12531 | 0.020 |
Why?
|
Mutagenesis | 1 | 2013 | 1234 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2010 | 869 | 0.020 |
Why?
|
Allosteric Regulation | 1 | 2010 | 426 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2013 | 743 | 0.020 |
Why?
|
Fruit | 1 | 2014 | 1160 | 0.020 |
Why?
|
Vegetables | 1 | 2014 | 1196 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2009 | 617 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2803 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9335 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2013 | 4169 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2014 | 3465 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4713 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 944 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2008 | 465 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2011 | 1490 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3616 | 0.020 |
Why?
|
Molecular Conformation | 1 | 2008 | 548 | 0.020 |
Why?
|
Random Allocation | 1 | 2011 | 2394 | 0.020 |
Why?
|
Protein Stability | 1 | 2009 | 566 | 0.020 |
Why?
|
Solubility | 1 | 2008 | 1088 | 0.020 |
Why?
|
Research Design | 1 | 2022 | 6180 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29658 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4573 | 0.020 |
Why?
|
Transfection | 1 | 2014 | 5781 | 0.020 |
Why?
|
Drug Synergism | 1 | 2010 | 1754 | 0.020 |
Why?
|
Autoimmune Diseases | 2 | 2009 | 2250 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 1347 | 0.020 |
Why?
|
Models, Chemical | 1 | 2008 | 614 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3618 | 0.020 |
Why?
|
Rats | 2 | 2013 | 23711 | 0.020 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2009 | 545 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2009 | 1229 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2846 | 0.020 |
Why?
|
Protozoan Proteins | 1 | 2011 | 839 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1753 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 12766 | 0.020 |
Why?
|
Up-Regulation | 1 | 2014 | 4122 | 0.020 |
Why?
|
Models, Animal | 1 | 2011 | 2117 | 0.010 |
Why?
|
Middle Aged | 4 | 2020 | 220352 | 0.010 |
Why?
|
Thiazoles | 1 | 2010 | 1511 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 2138 | 0.010 |
Why?
|
Benzamides | 1 | 2009 | 1369 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2009 | 3602 | 0.010 |
Why?
|
Female | 5 | 2021 | 391270 | 0.010 |
Why?
|
Erythrocytes | 1 | 2011 | 2415 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10827 | 0.010 |
Why?
|
Plasmodium falciparum | 1 | 2011 | 1742 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2009 | 3800 | 0.010 |
Why?
|
Binding Sites | 1 | 2010 | 6048 | 0.010 |
Why?
|
Male | 5 | 2020 | 359744 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22023 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12159 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11071 | 0.010 |
Why?
|
Adult | 3 | 2020 | 219994 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11152 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2008 | 2418 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 22053 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7343 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2009 | 17624 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2009 | 4742 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 58741 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40165 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15789 | 0.010 |
Why?
|
Aged | 2 | 2014 | 169152 | 0.010 |
Why?
|
Risk Factors | 1 | 2014 | 74359 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2011 | 65017 | 0.000 |
Why?
|